Walgreens Boots Alliance Inc. (WBA)
NASDAQ (NGS) NASDAQ (NGS) Primary 
Walgreens Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Walgreens Boots Alliance, Inc. WBA will release earnings results for its fourth quarter, before the opening bell on Tuesday, Oct. 15.
Walgreens: A New Risk Just Emerged for the Stock
Can this pharmacy retailer overcome this latest threat?
Walgreens Q4 Earnings Preview: Don't Catch The Falling Knife
Walgreens (NASDAQ: WBA) is scheduled to report its fiscal Q4 2024 results on Tuesday, October 15 (Walgreens' fiscal ends in August). We expect the company to post mixed results, with revenue of $34.9 billion and earnings of $0.38 per share, compared to the consensus estimates of $35.7 billion and $0.36, respectively.
Walgreens Stock Desperately Needs a Post-Earnings Pop
Shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) are up 0.8% to trade at $8.99 this afternoon, brushing off this morning's price-target cut to $11 from $13 at Deutsche Bank.
Unlocking Q4 Potential of Walgreens (WBA): Exploring Wall Street Estimates for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for Walgreens (WBA), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended August 2024.
Is Walgreens Boots Alliance Inc (WBA) Set to Underperform? Analyzing the Factors Limiting Growth
Long-established in the Healthcare Providers & Services industry, Walgreens Boots Alliance Inc (WBA, Financial) has enjoyed a stellar reputation. It has recently witnessed a daily gain of 0.17%, juxtaposed with a three-month change of -13.27%.
Analysts Estimate Walgreens Boots Alliance (WBA) to Report a Decline in Earnings: What to Look Out for
Walgreens (WBA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
2 Ultra-High-Yield Dividend Stocks Are Near 52-Week Lows. Is It Time to Buy the Dips?
With yields of 8% or better at recent prices, these dividend payers are hard to ignore.
Walgreens Boots Alliance (WBA) Advances While Market Declines: Some Information for Investors
In the closing of the recent trading day, Walgreens Boots Alliance (WBA) stood at $8.88, denoting a +1.83% change from the preceding trading day.
Assessing WBA Before Q4 Earnings: How Should You Play the Stock?
A challenging retail environment and pharmacy trends are expected to cloud Walgreens' performance in the fourth quarter of fiscal 2024.
Walgreens names Optum's Jason Stenta as chief commercial officer
Walgreens Boots Alliance named ex-Optum executive Jason Stenta as the company's chief commercial officer on Monday.
Walgreens: No Catalysts To Drive A Turnaround
In addition to weak consumer behavior and retail pharmacy industry headwinds, app downloads data suggests Walgreens is lagging vs. competition such as CVS. WBA has missed on margin expectations for multiple quarters now, and these pressures are expected to continue due to a tough pricing environment. Despite trough discount valuations vs. comps, WBA stock is in a value trap as the stock falls primarily due to earnings downgrades in the absence of catalysts.
